Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03144804
Title A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

colon adenocarcinoma

Therapies

Lamivudine

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST